"Off-label" is a medical term.
It means a treatment is being used outside the condition it was approved to treat — usually because the research was built around a different patient.
In women's health, off-label isn't the exception. It's the pattern.
The health system funds, designs, and communicates around demographic assumptions. Midlife health, cardiovascular disease, mental health, caregiving — the experiences that fall outside the standard frame get researched late, addressed late, and communicated poorly, if at all.
Organizations doing serious work in women's health often carry communications built on the same assumptions as the systems they're trying to improve: that the standard frame fits, that the standard channels reach people, that trust can be assumed rather than built.
It usually can't. Not with women who've been given the wrong information, in the wrong language, at the wrong time — by institutions that didn't think to ask.
Off Label exists to close that gap.